Thrombophilia in childhood: To test or not to test

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 7, 2011, Pages 794-801

  Heleen Van Ommen, C ^a   Middeldorp, Saskia ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

pediatrics; Thrombophilia; venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; DISEASE ASSOCIATION; HUMAN; IMMOBILIZATION; MUTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

ADOLESCENT; ADULT; ANTICOAGULANTS; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; CHILD; DIAGNOSTIC TESTS, ROUTINE; FACTOR V; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MUTATION; PREGNANCY; PREVALENCE; PROTEIN C; PROTEIN C DEFICIENCY; PROTEIN S; PROTEIN S DEFICIENCY; PROTHROMBIN; RECURRENCE; THROMBOPHILIA;

EID: 84055212125     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1297170     Document Type: Review

References (45)

1. Andrew M, David M, Adams M et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994 83 5 1251-1257 (Pubitemid 24062848)
2. van Ommen C H., Heijboer H, Büller H R., Hirasing R A., Heijmans H S., Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001 139 5 676-681 (Pubitemid 33097433)
3. Raffini L, Huang Y S., Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009 124 4 1001-1008
4. Manco-Johnson M J. Etiopathogenesis of pediatric thrombosis. Hematology 2005 10 Suppl 1 167-170 (Pubitemid 41825716)
5. Virchow R. Phlogose and thrombose im Gefässsystem. In: Virchow R ed. Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Frankfurt Von Meidinger Sohn 1856 458-636
6. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997 76 3 F163-F167
7. Young G, Albisetti M, Bonduel M et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 2008 118 13 1373-1382
8. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965 13 516-530
9. Tait R C., Walker I D., Perry D J. et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994 87 1 106-112 (Pubitemid 24207007)
10. Griffin J H., Evatt B, Zimmerman T S., Kleiss A J., Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981 68 5 1370-1373 (Pubitemid 12235040)
11. Tait R C., Walker I D., Reitsma P H. et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995 73 1 87-93
12. Kroiss S, Albisetti M. Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency. Biologics 2010 4 51-60
13. Comp P C., Nixon R R., Cooper M R., Esmon C T. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984 74 6 2082-2088 (Pubitemid 15197352)
14. Mahasandana C, Suvatte V, Chuansumrit A et al. Homozygous protein S deficiency in an infant with purpura fulminans. J Pediatr 1990 117 5 750-753 (Pubitemid 20382610)
15. Dahlbäck B, Carlsson M, Svensson P J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993 90 3 1004-1008 (Pubitemid 23053939)
16. Bertina R M., Koeleman BPC, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994 369 6475 64-67 (Pubitemid 24144355)
17. Rees D C., Cox M, Clegg J B. World distribution of factor V Leiden. Lancet 1995 346 8983 1133-1134
18. Poort S R., Rosendaal F R., Reitsma P H., Bertina R M. A common genetic variation in the 3-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996 88 10 3698-3703 (Pubitemid 26383091)
19. Rosendaal F R., Doggen C J., Zivelin A et al. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998 79 4 706-708 (Pubitemid 28163839)
20. Tripodi A, Chantarangkul V, Menegatti M, Tagliabue L, Peyvandi F. Performance of clinical laboratories for DNA analyses to detect thrombophilia mutations. Clin Chem 2005 51 7 1310-1311 (Pubitemid 43079432)
21. Favaloro E J., McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost 2009 35 7 695-710
22. Monagle P, Barnes C, Ignjatovic V et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006 95 2 362-372
23. van Teunenbroek A, Peters M, Sturk A, Borm J J., Breederveld C. Protein C activity and antigen levels in childhood. Eur J Pediatr 1990 149 11 774-778 (Pubitemid 20290953)
24. Kenet G, Lütkhoff L K., Albisetti M et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 2010 121 16 1838-1847
25. Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost 2003 1 5 915-921
26. van Ommen C H., Heijboer H, van den Dool E J., Hutten B A., Peters M. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost 2003 1 12 2516-2522
27. Bezemer I D., van der Meer F J., Eikenboom J C., Rosendaal F R., Doggen C J. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med 2009 169 6 610-615
28. van Sluis G L., Söhne M, El Kheir D Y., Tanck M W., Gerdes V E., Büller H R. Family history and inherited thrombophilia. J Thromb Haemost 2006 4 10 2182-2187 (Pubitemid 44400295)
29. Massicotte M P., Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998 133 6 770-776 (Pubitemid 28563947)
30. Monagle P, Adams M, Mahoney M et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000 47 6 763-766 (Pubitemid 30365435)
31. Lijfering W M., Brouwer J L., Veeger N J. et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 2009 113 21 5314-5322
32. Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003 362 9383 523-526 (Pubitemid 36976716)
33. Christiansen S C., Cannegieter S C., Koster T, Vandenbroucke J P., Rosendaal F R. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005 293 19 2352-2361 (Pubitemid 40676757)
34. Bates S M., Greer I A., Pabinger I, Sofaer S, Hirsh J, American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 133 6, Suppl 844S-886S (Pubitemid 351892978)
35. Baglin T, Gray E, Greaves M et al, British Committee for Standards in Haematology. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 2010 149 2 209-220
36. Tormene D, Simioni P, Prandoni P et al. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood 2002 100 7 2403-2405
37. Langlois N J., Wells P S. Risk of venous thromboembolism in relatives of symptomatic probands with thrombophilia: a systematic review. Thromb Haemost 2003 90 1 17-26 (Pubitemid 36873854)
38. Holzhauer S, Stoll M, Thedieck S et al. Prevalence of thrombophilia and incidence of symptomatic thromboembolism in first degree relatives of pediatric index cases: a prospective cohort study. J Thromb Haemost 2009 7 OC-TU-062
39. Calhoon M J., Ross C N., Pounder E, Cassidy D, Manco-Johnson M J., Goldenberg N A. High prevalence of thrombophilic traits in children with family history of thromboembolism. J Pediatr 2010 157 3 485-489
40. Green D. Genetic hypercoagulability: screening should be an informed choice. Blood 2001 98 1 20
41. O'Brien S H., Smith K J. Using thrombophilia testing to determine anticoagulation duration in pediatric thrombosis is not cost-effective. J Pediatr 2009 155 1 100-104
42. Wade C H., Wilfond B S., McBride C M. Effects of genetic risk information on children's psychosocial wellbeing: a systematic review of the literature. Genet Med 2010 12 6 317-326
43. Cohn D M., Vansenne F, Kaptein A A., De Borgie C A., Middeldorp S. The psychological impact of testing for thrombophilia: a systematic review. J Thromb Haemost 2008 6 7 1099-1104 (Pubitemid 351859118)
44. Coppola A, Tufano A, Cerbone A M., Di Minno G. Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost 2009 35 7 683-694
45. Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol 2008 143 3 321-335